Performance
Total traded value
0.71 CrFundamentals
| Market Cap | ₹64Cr |
| ROE | 4.59% |
| P/E Ratio(TTM) | 53.90 |
| EPS(TTM) | 0.50 |
| P/B Ratio | 2.46 |
| Dividend Yield | 0.00% |
| Industry P/E | 39.97 |
| Book Value | 10.96 |
| Debt to Equity | 0.02 |
| Face Value | 10 |
Financials
*All values are in Rs. Cr
About Kabra Drugs
Kabra Drugs Limited is a public company established to operate in the pharmaceutical sector by manufacturing and trading pharma-related products. The company's future development is entirely dependent on the successful commencement of its operational activities. Due to a shortage of funds, the company could not perform any business activities during the year under review. In response, several cost-cutting measures have already been undertaken by the company to prepare for future operations. The Company believes that its human capital is its biggest asset and it greatly values its human resources. As part of its strategy, the company has planned to shift its registered office from Madhya Pradesh to Tamil Nadu.;
| Parent Organisation | Kabra Drugs Limited |
| Managing Director | N. ARAVIND |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25